基本信息
浏览量:7
职业迁徙
个人简介
Dr. Kloiber’s clinical expertise and research focuses on mood and anxiety disorders. A major focus of Dr. Kloiber's clinical research is to investigate novel neurobiological systems including the brain endocannabinoid system in mood and anxiety disorders as well as to explore novel treatment approaches through clinical trials with a specific interest in neurobiological and clinical effects of cannabinoids. Research projects in this field include clinical studies evaluating the effects of cannabinoids, e.g. cannabidiol (CBD) and projects to understand perceptions and motivations for cannabis use in mood and anxiety disorders, as well as neuroimaging / positron emission tomography (PET) studies evaluating the brain endocannabinoid system in the with mood and anxiety disorders, healthy controls and the effect of cannabinoids such as THC on the brain endocannabinoid system.
Another aspect of Dr. Kloiber’s work is focused on improving treatment of mood and anxiety disorders by standardizing and individualizing therapy through Integrated Care Pathways (ICPs) and biomarker research combining various strategies such as genomics, neuroendocrinology, metabolomics, digital behavioral phenotyping and psychophysiology. With this approach Dr. Kloiber aims to detect individual biological signatures for prediction of treatment response, prevention of adverse events, and subclassification of mood and anxiety disorders.
Another aspect of Dr. Kloiber’s work is focused on improving treatment of mood and anxiety disorders by standardizing and individualizing therapy through Integrated Care Pathways (ICPs) and biomarker research combining various strategies such as genomics, neuroendocrinology, metabolomics, digital behavioral phenotyping and psychophysiology. With this approach Dr. Kloiber aims to detect individual biological signatures for prediction of treatment response, prevention of adverse events, and subclassification of mood and anxiety disorders.
研究兴趣
论文共 191 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Brain sciencesno. 3 (2024)
Pharmacopsychiatry (2024)
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIEno. 3 (2024): 183-195
BRAIN SCIENCESno. 12 (2023)
EUROPEAN PSYCHIATRY (2023): S557-S557
引用0浏览0引用
0
0
Clinical pharmacology and therapeuticsno. 1 (2023): 88-117
Psychiatric Geneticsno. 4 (2023): 123-133
Anna R. Docherty,Niamh Mullins,Allison E. Ashley-Koch,Xuejun Qin,Jonathan R. I. Coleman,Andrey Shabalin, JooEun Kang, Balasz Murnyak,Frank Wendt,Mark Adams,Adrian I. Campos,Emily DiBlasi,
Anna R Docherty,Niamh Mullins,Allison E Ashley-Koch,Xuejun Qin,Jonathan R I Coleman,Andrey Shabalin, JooEun Kang, Balasz Murnyak,Frank Wendt,Mark Adams,Adrian I Campos,Emily DiBlasi,
medRxiv (Cold Spring Harbor Laboratory) (2023)
引用3浏览0引用
3
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn